PTGS2 and chronic obstructive pulmonary disease: A cyclooxygenase-2 (COX-2) mediated increase in prostaglandin E2 (PGE2) might be linked to disease development, including impaired endothelial barrier function, asthma, COPD, as well as lung injury.